Nicholas J. Petrelli

Q: What Schools Are Affiliated With Nicholas J. Petrelli

Nicholas J. Petrelli is affiliated with the following schools: University of Pittsburgh, Thomas Jefferson University

Nicholas J. Petrelli's AcademicInfluence.com Rankings

Medical

#2384

World Rank

#2806

Historical Rank

Oncology

#143

World Rank

#148

Historical Rank

medical Degrees

Nicholas J. Petrelli

Philosophy

#6942

World Rank

#10071

Historical Rank

Logic

#4023

World Rank

#5264

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Why Is Nicholas J. Petrelli Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Nicholas J. Petrelli's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Comprehensive molecular portraits of human breast tumors (2012) (7791)
Integrated Genomic Analyses of Ovarian Carcinoma (2011) (6411)
Comprehensive molecular characterization of human colon and rectal cancer (2012) (6141)
Comprehensive genomic characterization of squamous cell lung cancers (2012) (2998)
Comprehensive molecular characterization of urothelial bladder carcinoma (2014) (1748)
Aberrant CpG-island methylation has non-random and tumour-type–specific patterns (2000) (1397)
Guidelines 2000 for colon and rectal cancer surgery. (2001) (1270)
A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. (2003) (1150)
Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. (1996) (961)
Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07. (2007) (954)
Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. (2016) (931)
Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03. (2009) (835)
MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells. (2007) (825)
Integrated genomic and molecular characterization of cervical cancer (2017) (762)
The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03. (1993) (656)
Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline. (2005) (583)
Oxaliplatin as adjuvant therapy for colon cancer: updated results of NSABP C-07 trial, including survival and subset analyses. (2011) (576)
Phase III trial assessing bevacizumab in stages II and III carcinoma of the colon: results of NSABP protocol C-08. (2011) (557)
Resection of the liver for colorectal carcinoma metastases (1988) (509)
The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial. Gastrointestinal Tumor Study Group. (1989) (508)
Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02. (2000) (506)
A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma. (1987) (417)
The onset and extent of genomic instability in sporadic colorectal tumor progression. (1999) (404)
A clinical trial to evaluate the worth of preoperative multimodality therapy in patients with operable carcinoma of the rectum (1997) (384)
A review of the evolution of systemic chemotherapy in the management of colorectal cancer. (2015) (378)
A prospective evaluation of hepatic resection for colorectal carcinoma metastases to the liver: Gastrointestinal Tumor Study Group Protocol 6584. (1991) (369)
The Modulation of Fluorouracil With Leucovorin in Metastatic Colorectal Carcinoma A Prospective Randomized Phase III Trial (1990) (363)
Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04. (2014) (354)
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in the Management of Peritoneal Surface Malignancies of Colonic Origin: A Consensus Statement (2006) (339)
Oral uracil and tegafur plus leucovorin compared with intravenous fluorouracil and leucovorin in stage II and III carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project Protocol C-06. (2006) (317)
Enhanced levels of insulin-like growth factor messenger RNA in human colon carcinomas and liposarcomas. (1986) (317)
Aspirin use, cancer, and polyps of the large bowel (1993) (297)
Follow-up care, surveillance protocol, and secondary prevention measures for survivors of colorectal cancer: American Society of Clinical Oncology clinical practice guideline endorsement. (2013) (288)
Metastases in small lymph nodes from colon cancer. (1987) (278)
Mutation Profiling and Microsatellite Instability in Stage II and III Colon Cancer: An Assessment of Their Prognostic and Oxaliplatin Predictive Value (2012) (272)
Extending the frontiers of surgical therapy for hepatic colorectal metastases: is there a limit? (2005) (265)
Age and sex are independent predictors of 5‐fluorouracil toxicity. Analysis of a large scale phase III trial (1995) (259)
Initial safety report of NSABP C-08: A randomized phase III study of modified FOLFOX6 with or without bevacizumab for the adjuvant treatment of patients with stage II or III colon cancer. (2009) (248)
The organization of multidisciplinary care teams: modeling internal and external influences on cancer care quality. (2010) (225)
Flow cytometric analysis of DNA aneuploidy in primary and metastatic human solid tumors. (1984) (214)
The impact of capecitabine and oxaliplatin in the preoperative multimodality treatment in patients with carcinoma of the rectum: NSABP R-04. (2011) (211)
Recommended colorectal cancer surveillance guidelines by the American Society of Clinical Oncology. (1999) (206)
Meta-analysis of randomized trials testing the biochemical modulation of fluorouracil by methotrexate in metastatic colorectal cancer (1994) (205)
Bevacizumab in stage II-III colon cancer: 5-year update of the National Surgical Adjuvant Breast and Bowel Project C-08 trial. (2013) (184)
Consensus Guidelines from The American Society of Peritoneal Surface Malignancies on Standardizing the Delivery of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Colorectal Cancer Patients in the United States (2013) (170)
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Society of Surgical Oncology. (2007) (165)
Phase I-II trial of high-dose calcium leucovorin and 5-fluorouracil in advanced colorectal cancer. (1984) (159)
Hepatic resection: the last surgical frontier for colorectal cancer. (2005) (157)
Hamartomatous Polyposis Syndromes: Molecular Genetics, Neoplastic Risk, and Surveillance Recommendations (2001) (156)
Phase II trial of fluorouracil and recombinant interferon alfa-2a in patients with advanced colorectal carcinoma: an Eastern Cooperative Oncology Group study. (1991) (152)
Initial clinical (phase I) trial of TLC D-99 (doxorubicin encapsulated in liposomes). (1993) (150)
Clinical Outcome From Oxaliplatin Treatment in Stage II/III Colon Cancer According to Intrinsic Subtypes: Secondary Analysis of NSABP C-07/NRG Oncology Randomized Clinical Trial. (2016) (149)
2000 update of American Society of Clinical Oncology colorectal cancer surveillance guidelines. (2000) (145)
Concerted nonsyntenic allelic loss in human colorectal carcinoma. (1988) (142)
Primary mFOLFOX6 plus bevacizumab without resection of the primary tumor for patients presenting with surgically unresectable metastatic colon cancer and an intact asymptomatic colon cancer: definitive analysis of NSABP trial C-10. (2012) (142)
Desmoid tumors in patients with familial adenomatous polyposis (1994) (138)
Biofunctionalization of electrospun PCL-based scaffolds with perlecan domain IV peptide to create a 3-D pharmacokinetic cancer model. (2010) (123)
Clinical utility of external immunoscintigraphy with the IMMU-4 technetium-99m Fab' antibody fragment in patients undergoing surgery for carcinoma of the colon and rectum: results of a pivotal, phase III trial. The Immunomedics Study Group. (1996) (123)
Clinical Cancer Advances 2009: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology. (2009) (113)
Long-Term Survival Results of Surgery Alone Versus Surgery Plus 5-Fluorouracil and Leucovorin for Stage II and Stage III Colon Cancer: Pooled Analysis of NSABP C-01 Through C-05. A Baseline from Which to Compare Modern Adjuvant Trials (2010) (109)
Surgical resection of pulmonary metastases from colorectal adenocarcinoma (1985) (106)
3D Matrices for Anti-Cancer Drug Testing and Development (2010) (106)
Clinical significance of colorectal cancer: Metastases in lymph nodes <5 mm in size (2006) (101)
A Comprehensive Patient-Derived Xenograft Collection Representing the Heterogeneity of Melanoma. (2017) (100)
Primary signet-ring cell carcinoma of the colon and rectum (2006) (99)
Hepatic resection for isolated metastasis from colorectal carcinoma. (1985) (93)
Squamous cell carcinoma of the anal canal. (2005) (92)
Photodynamic therapy in patients with colorectal cancer (1986) (89)
Morbidity and mortality after pelvic exenteration for colorectal adenocarcinoma. (1992) (88)
Metastases to the lymph nodes in epidermoid carcinoma of the anal canal studied by a clearing technique. (1989) (87)
Genomic DNA-based hMSH2 and hMLH1 mutation screening in 32 Eastern United States hereditary nonpolyposis colorectal cancer pedigrees. (1997) (84)
An anoxia inducible endonuclease and enhanced DNA breakage as contributors to genomic instability in cancer. (1995) (84)
Modern multimodality approach to hepatic colorectal metastases: solutions and controversies. (2007) (83)
Results of surgical resection of pulmonary metastases of squamous cell carcinoma of the head and neck. (1992) (83)
Prevention of chronic radiation enteritis. (1999) (78)
Colonocyte differentiation is associated with increased expression and altered distribution of protein kinase C isozymes. (1998) (78)
Nasogastric decompression following elective colorectal surgery: a prospective randomized study. (1993) (77)
Spouse adjustment to cancer surgery: Distress and coping responses (1990) (76)
Biochemical and pharmacologic basis for potentiation of 5-fluorouracil action by leucovorin. (1987) (75)
Early Postoperative Oral Feeding After Colectomy: An Analysis of Factors That May Predict Failure (2001) (73)
Microfabricated electrospun collagen membranes for 3-D cancer models and drug screening applications. (2009) (71)
Adenosquamous carcinoma of the colon and rectum (1996) (70)
Osseous metastases from colorectal carcinoma. (1986) (68)
Prognosis and recurrence patterns of anal adenocarcinoma. (1995) (68)
A phase I and pharmacokinetic study of oral uracil, ftorafur, and leucovorin in patients with advanced cancer (1996) (67)
Resection of lung metastases from soft-tissue sarcomas. A multivariate analysis. (1992) (64)
Plasma and tumor tissue pharmacology of high-dose intravenous leucovorin calcium in combination with fluorouracil in patients with advanced colorectal carcinoma. (1988) (64)
Pelvic exenteration and its modifications. (1996) (63)
Life‐long screening of patients with intermediate‐thickness cutaneous melanoma for asymptomatic pulmonary recurrences (1997) (63)
Morbidity and mortality following abdominoperineal resection for rectal adenocarcinoma. (1993) (63)
Immunochemical versus guaiac occult blood stool tests: results of a community-based screening program. (1994) (63)
NCCN Practice Guidelines for Colorectal Cancer. (2000) (62)
Intraoperative determinants of unresectability for patients with colorectal hepatic metastases (1998) (61)
Genomic instability in sporadic colorectal cancer quantitated by inter‐simple sequence repeat PCR analysis (1997) (61)
Rectal cancer in hereditary nonpolyposis colorectal cancer. (2001) (61)
Molecular prognostics in colorectal cancer. (2003) (60)
The value of colonoscopic surveillance after curative resection for colorectal cancer or synchronous adenomatous polyps. (1987) (60)
Intrachromosomal genomic instability in human sporadic colorectal cancer measured by genome-wide allelotyping and inter-(simple sequence repeat) PCR. (2001) (59)
Defective mismatch repair and benefit from bevacizumab for colon cancer: findings from NSABP C-08. (2013) (58)
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in the Management of Peritoneal Surface Malignancies of Colonic Origin: A Consensus Statement (2007) (58)
Sexual dysfunction, informed consent and multimodality therapy for rectal cancer. (2000) (58)
Use of carcinoembryonic antigen radioimmunodetection and computed tomography for predicting the resectability of recurrent colorectal cancer. (1997) (58)
Colorectal adenocarcinoma in patients less than 40 years of age (1991) (56)
Anal canal and perianal epidermoid cancers. (1997) (55)
Perioperative or adjuvant therapy for resectable colorectal hepatic metastases. (2008) (54)
p53 tumor suppressor gene status and the degree of genomic instability in sporadic colorectal cancers. (1996) (52)
Novel hMLH1 and hMSH2 germline mutations in African Americans with colorectal cancer. (1999) (52)
Treatment of bowel obstruction after operation for colorectal carcinoma. (1988) (51)
Genetic and Genomic Characterization of 462 Melanoma Patient-Derived Xenografts, Tumor Biopsies, and Cell Lines. (2017) (51)
Rectal cancer surgery: a brief history. (2011) (50)
Clinical cancer advances 2010: annual report on progress against cancer from the American Society of Clinical Oncology. (2010) (50)
Familial and nutritional risk factors for p53 overexpression in colorectal cancer. (1996) (50)
Analysis of Epstein-Barr virus reservoirs in paired blood and breast cancer primary biopsy specimens by real time PCR (2006) (49)
Hepatic artery ligation for liver metastasis in colorectal carcinoma (1984) (49)
Morbidity and survival of liver resection for colorectal adenocarcinoma (1991) (48)
Sentinel lymph node biopsy in breast cancer: a history and current clinical recommendations. (2012) (48)
Photodynamic therapy in the management of neoplasms of the perianal skin. (1992) (48)
Use of vitamins, minerals, and nutritional supplements by participants in a chemoprevention trial (2001) (48)
Colorectal Villous and Tubulovillous Adenomas Equal to or Greater than Four Centimeters (1988) (47)
Photodynamic therapy for residual neoplasms of the perianal skin (2000) (46)
p53 tumor suppressor gene mutations predict decreased survival of patients with sporadic colorectal carcinoma (2000) (45)
The management of infectious and noninfectious anorectal complications in patients with leukemia. (1996) (44)
Identification of DNA Methylation in 3' Genomic Regions that are Associated with Upregulation of Gene Expression in Colorectal Cancer (2007) (41)
Postoperative complications after splenectomy for hematologic malignancies. (1996) (41)
Chemotherapy and Regional Therapy of Hepatic Colorectal Metastases: Expert Consensus Statement (2006) (40)
Does more intense palliative treatment improve overall survival in metastatic breast cancer patients? (1986) (39)
Evaluation of alpha-difluoromethylornithine as a potential chemopreventive agent: tolerance to daily oral administration in humans. (1993) (39)
Bowel rest, intravenous hydration, and continuous high‐dose infusion of octreotide acetate for the treatment of chemotherapy‐induced diarrhea in patients with colorectal carcinoma (1993) (39)
Establishment of a hereditary nonpolyposis colorectal cancer registry (1996) (38)
Clinical implications of multiple colorectal carcinomas in hereditary nonpolyposis colorectal carcinoma (1999) (38)
Anastomotic recurrence of adenocarcinoma of the colon. (1986) (37)
Evaluation and management of incidentally discovered thyroid nodules. (2006) (37)
Epigenetic silencing of Na,K-ATPase β1 subunit gene ATP1B1 by methylation in clear cell renal cell carcinoma (2014) (36)
Curative resection for stage I rectal cancer: natural history, prognostic factors, and recurrence patterns. (1996) (36)
Response to preoperative multimodality therapy predicts survival in patients with carcinoma of the rectum. (2004) (36)
Intraoperative small bowel enteroscopy in familial adenomatous and familial juvenile polyposis. (1995) (35)
Patterns of recurrence after pelvic exenteration for colorectal adenocarcinoma. (1991) (34)
Quality of colonoscopy reporting: a process of care study (2000) (34)
Advanced cutaneous squamous cell carcinoma of the trunk and extremity: Analysis of prognostic factors (1997) (34)
Long-Term Survival in Patients With Ovarian Metastases From Colorectal Carcinoma (1999) (33)
Genome-wide allelotyping indicates increased loss of heterozygosity on 9p and 14q in early age of onset colorectal cancer (1999) (32)
Response to preoperative multimodality therapy predicts survival in patients with carcinoma of the rectum (2004) (32)
The effect of cardiopulmonary lymphatic obstruction on heart and lung function. (2001) (32)
The application of tissue adhesives in small bowel anastomoses (1982) (31)
Endobronchial metastasis from colorectal carcinoma (1984) (31)
Squamous cell carcinoma antigen as a marker for squamous cell carcinoma of the anal canal. (1988) (31)
Localization of Endogenous β-Galactoside-Binding Lectin in Human Cells and Tissues (1991) (31)
Long-term survival in patients with ovarian metastases from colorectal carcinoma (1998) (30)
The relationship between smoking exposure and p53 overexpression in colorectal cancer. (1996) (30)
Priorities in colorectal cancer research: recommendations from the Gastrointestinal Scientific Leadership Council of the Coalition of Cancer Cooperative Groups. (2007) (30)
Validation of a new classification system for curatively resected colorectal adenocarcinoma (1999) (30)
Genomic heterogeneity and instability in colorectal cancer: spectral karyotyping, glutathione transferase-Ml and ras. (2004) (29)
Accuracy of biopsy and cytology for the preoperative diagnosis of colorectal adenocarcinoma (1999) (29)
Primary adenocarcinoma arising in an ileostomy. (1993) (28)
Colorectal cancer in patients aged 30 years or younger. (1996) (28)
Phase II study of combination bleomycin, vincristine and high-dose methotrexate (BOM) with leucovorin rescue in advanced squamous cell carcinoma of the anal canal (2004) (28)
Complications of absorbable pelvic mesh slings following surgery for rectal carcinoma (1997) (28)
No treatment option for liver metastases from colorectal adenocarcinoma (1989) (28)
Neoadjuvant rectal cancer (RC) score to predict survival: Potential surrogate endpoint for early-phase trials. (2014) (28)
Folates as adjuvants to anticancer agents: Chemical rationale and mechanism of action. (2016) (27)
The utility of squamous cell carcinoma antigen for the follow‐up of patients with squamous cell carcinoma of the anal canal (1992) (27)
Local excision for rectal cancer: an uncertain future. (1998) (27)
Hepatic Resection at a Major Community-Based Teaching Hospital Can Result in Good Outcome (2005) (27)
A comparison of the 25‐cm rigid proctosigmoidoscope with the 65‐cm flexible endoscope in the screening of patients for colorectal carcinoma (1986) (27)
The Toxicity of Liver Directed Yttrium-90 Microspheres in Primary and Metastatic Liver Tumors (2008) (27)
A comparison of ornithine decarboxylase and S-adenosylmethionine decarboxylase activity in human large bowel mucosa, polyps, and colorectal adenocarcinoma. (1987) (26)
Neoadjuvant therapy for rectal cancer: Mature results from NSABP protocol R-04. (2014) (26)
Major pancreatic resections for suspected cancer in a community‐based teaching hospital: Lessons learned (2007) (26)
Safety and efficacy of arcitumomab imaging in colorectal cancer after repeated administration. (2000) (26)
Severe life-threatening toxicities observed in study using leucovorin with 5-fluorouracil. (1987) (25)
The debate is over; it's time to move on. (2004) (25)
Health, life, and disability insurance and hereditary nonpolyposis colorectal cancer. (1998) (25)
Anal canal and perianal epidermoid cancers (1997) (25)
Primaryde novo adenocarcinoma of the colon measuring 8 mm in diameter with lymph node metastases (1991) (25)
Follow-up colonoscopy in patients with colorectal adenomatous polyps (1987) (24)
The Roswell Park Memorial Institute and Gastrointestinal Tumor Study Group phase III experience with the modulation of 5-fluorouracil by leucovorin in metastatic colorectal adenocarcinoma. (1988) (24)
Prognostic factors affecting survival in patients with colorectal carcinomatosis. (1999) (24)
Total mesorectal excision and pelvic node dissection for rectal cancer: an appraisal. (2007) (24)
Laser palliation for colorectal carcinoma. (1991) (23)
In vivo determinations of labelling index of metastatic colorectal carcinoma and normal colonic mucosa using intravenous infusions of bromodeoxyuridine (1988) (23)
Clinicopathologic effects of cryotherapy on hepatic vessels and bile ducts in a porcine model (2006) (23)
Prognostic significance of anastomotic recurrence from colorectal adenocarcinoma (1992) (23)
Local Excision of Rectal Carcinoma (2001) (22)
The efficacy of oxaliplatin (Ox) when added to 5-fluorouracil/leucovorin (FU/L) in stage II colon cancer. (2011) (22)
Responsibility for costs associated with clinical trials. (2014) (22)
Local recurrence after sphincter-saving resection for rectal adenocarcinoma. (1989) (22)
Metastatic colorectal cancer: advances in biochemical modulation and new drug development. (1995) (21)
Peritoneal surface malignancies and regional treatment: a review of the literature. (2012) (21)
Pelvic and perineal recurrences after abdominoperineal resection for adenocarcinoma of the rectum. (1985) (21)
aCGH local copy number aberrations associated with overall copy number genomic instability in colorectal cancer: coordinate involvement of the regions including BCR and ABL. (2007) (21)
Common peroneal nerve palsy associated with pelvic surgery for cancer (1986) (21)
The role of colonoscopy and flexible sigmoidoscopy in screening for Colorectal Carcinoma (1987) (21)
A Statewide Community Cancer Center Videoconferencing Program (2008) (21)
Final results from NSABP protocol R-04: Neoadjuvant chemoradiation (RT) comparing continuous infusion (CIV) 5-FU with capecitabine (Cape) with or without oxaliplatin (Ox) in patients with stage II and III rectal cancer. (2014) (21)
Is it cost-effective to add erlotinib to gemcitabine in advanced pancreatic cancer? (2006) (21)
The prognostic value of preoperative alkaline phosphatase for resection of solitary liver metastasis from colorectal carcinoma. (1987) (20)
A phase II trial of 5-fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6) chemotherapy plus bevacizumab (bev) for patients (pts) with unresectable stage IV colon cancer and a synchronous asymptomatic primary tumor: Results of NSABP C-10. (2010) (20)
Surgery for recurrent rectal adenocarcinoma in the presence of hydronephrosis. (1992) (20)
Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds (2016) (19)
Is there a role for curative surgery for pelvic recurrence from rectal carcinoma in the presence of hydronephrosis? (2001) (19)
Editorial. (2020) (19)
ReCAP: Impact of Multidisciplinary Care on Processes of Cancer Care: A Multi-Institutional Study. (2016) (18)
Absorbable mesh sling prevents radiation-induced bowel injury during "sandwich" chemoradiation for rectal cancer. (2000) (18)
Commentary (Petrelli): Managing the Peritoneal Surface Component of Gastrointestinal Cancer (2004) (18)
ReCAP: Impact of Multidisciplinary Care on Processes of Cancer Care: A Multi-Institutional Study. (2016) (18)
Utility of routine postoperative laboratory studies in patients undergoing potentially curative resection for adenocarcinoma of the colon and rectum. (1999) (18)
Isolated metachronous metastases to soft tissues of the buttock from a colonic adenocarcinoma (1985) (18)
A proposed classification system for liver metastasis from colorectal carcinoma (1984) (17)
Clinical trial investigator status: you need to earn it. (2008) (17)
Accuracy of colonoscopy for the detection of colorectal polyps (1992) (17)
The clinical and genetic manifestations of hereditary nonpolyposis colorectal carcinoma. (1995) (17)
Seizures associated with leucovorin administration in cancer patients. (1995) (17)
Detection of pelvic recurrence of colorectal carcinoma: prospective, blinded comparison of Tc-99m-IMMU-4 monoclonal antibody scanning and CT. (1995) (17)
PHASE II TRIAL OF PACLITAXEL IN PATIENTS WITH ADVANCED COLON CANCER PREVIOUSLY UNTREATED WITH CYTOTOXIC CHEMOTHERAPY: AN EASTERN COOPERATIVE ONCOLOGY GROUP TRIAL (PA286) (1996) (17)
A pilot study of cryochemotherapy for hepatic metastases from colorectal cancer. (1996) (16)
Inguinal lymph node metastases from adenocarcinoma of the rectum. (1994) (16)
An analysis of chemotherapy for colorectal carcinoma (1984) (16)
Disseminated Peritoneal Adenomucinosis: A Critical Review (1999) (16)
Intraoperative Hepatic Lymphatic Mapping in Patients with Liver Metastases from Colorectal Carcinoma (2002) (16)
Severe and fatal toxic effects observed in treatment with high- and low-dose leucovorin plus 5-fluorouracil for colorectal carcinoma. (1987) (16)
Intrathecal phenol rhizotomy for management of pain in recurrent unresectable carcinoma of the rectum. (1992) (16)
Expressing the Prochemotherapy Position on Treatment of Synchronous Colorectal Metastases in the Asymptomatic Patient (2006) (15)
Endoscopic laser treatment for palliation of colorectal adenocarcinoma. (1993) (15)
Factors affecting the morbidity of elective liver resection. (1988) (15)
Carcinoma of the gallbladder. (1998) (15)
Aspirin use and p53 expression in colorectal cancer. (1998) (15)
New Approach to the Substaging of Node-Positive Colorectal Adenocarcinoma (1999) (15)
Endoscopy versus double-contrast barium enema in the evaluation of patients with symptoms suggestive of colorectal carcinoma. (1988) (15)
Primary colorectal non-Hodgkin's lymphoma (1994) (14)
Outcomes of gastric cancer resections performed in a high volume community cancer center. (2015) (14)
A randomized trial of aspirin to prevent colorectal adenomas in patients with previous (2003) (14)
Genomic profiles of colorectal cancers differ based on patient smoking status. (2006) (14)
Abdominal exploration for suspected recurrent carcinoma of the colon and rectum based upon elevated carcinoembryonic antigen alone or in combination with other diagnostic methods. (1986) (14)
Serum levels of cancer‐associated antigen ca‐195 in gastrointestinal cancers and its comparison with ca19‐9 (1989) (14)
The use of videotaped lectures in surgical oncology fellowship education. (2009) (14)
Intraoperative endoscopy in the management of patients with colorectal disease. (1998) (14)
The half century of clinical trials of the National Surgical Adjuvant Breast And Bowel Project. (2008) (14)
99mTc-IMMU-4 monoclonal antibody scan in colorectal cancer. A prospective study. (1992) (14)
The pathophysiology of the jejunal conduit syndrome and its exacerbation by parenteral hyperalimentation (1984) (13)
Predictive Biomarkers and Personalized Medicine MutationPro fi ling andMicrosatellite Instability in Stage II and III Colon Cancer : An Assessment of Their Prognostic and Oxaliplatin Predictive Value (2012) (13)
Patterns of colorectal liver metastases according to Couinaud's segments (1995) (13)
Utility of mapping lymph nodes cleared from rectal adenocarcinoma specimens. (1996) (13)
Knockdown of sodium–calcium exchanger 1 induces epithelial-to-mesenchymal transition in kidney epithelial cells (2017) (13)
Metastasis to the parotid gland from colorectal adenocarcinoma (1985) (13)
Overall survival (OS) and updated disease-free survival (DFS) results of the NSABP C-08 trial assessing bevacizumab (B) in stage II and III colon cancer. (2011) (12)
Is abdominoperineal resection a good option for stage IV adenocarcinoma of the distal rectum? (2002) (12)
Glucocorticoids Suppress Renal Cell Carcinoma Progression by Enhancing Na,K-ATPase Beta-1 Subunit Expression (2015) (12)
Randomized, placebo-controlled, multicenter trial of granulocyte-macrophage colony-stimulating factor as infection prophylaxis in oncologic surgery. Leukine Surgical Prophylaxis Research Group. (1998) (11)
Massive screening for colorectal cancer. A single institution's public commitment. (1990) (11)
Overview of anal cancer for the surgeon. (2004) (11)
A prospective, randomized trial of perioperative prophylactic cefamandole in elective colorectal surgery for malignancy (1988) (11)
Incidence of urinary tract infections in patients requiring long-term catheterization after abdominoperineal resection for rectal carcinoma: does Betadine in the Foley drainage bag make a difference? (1987) (11)
A community cancer center program: getting to the next level. (2010) (11)
Update on design of the National Surgical Adjuvant Breast and Bowel Project trial R-04. (2005) (10)
Perineal dissection of synchronous abdominoperineal resection of the rectum: an anatomical description. (2003) (10)
High volume pancreaticoduodenectomy performed at an academic community cancer center. (2019) (10)
Wide perineal dissection and its effect on local recurrence following potentially curative abdominoperineal resection for rectal adenocarcinoma. (1996) (10)
Cooperative Group Trials in the Community Setting. (2015) (10)
Systemic chemotherapy should be the primary treatment of synchronous colorectal metastases in the asymptomatic patient [corrected]. (2006) (10)
Mixed juvenile‐adenomatous polyp of the rectum in an elderly patient (1985) (10)
Intergroup Randomized Phase III Study of Postoperative Oxaliplatin, 5-Fluorouracil, and Leucovorin Versus Oxaliplatin, 5-Fluorouracil, Leucovorin, and Bevacizumab for Patients with Stage II or III Rectal Cancer Receiving Preoperative Chemoradiation: A Trial of the ECOG-ACRIN Research Group (E5204). (2019) (10)
Subcutaneous metastases without visceral metastases from an adenocarcinoma of the rectum (1985) (9)
Cardiopulmonary resuscitation inpatient outcomes in cancer patients in a large community hospital. (2012) (9)
Esophagogastric anastomoses in rats--an experimental model. (1999) (9)
Not just another article on cancer surgery volume and patient outcomes. (2008) (9)
Modified Pelvic Exenterations (1994) (9)
It is time to stratify with prognostic factors for hepatic metastases. (1995) (9)
Desmoid tumors. (1996) (9)
The effect of keratinocyte growth factor-2 on esophagogastric anastomotic wound healing in rats. (1999) (9)
Factors Associated with Nodal Involvement of Rectal Adenocarcinomas (1992) (8)
Circulating CA-195 in colorectal cancer (1987) (8)
Hepatic Lymphatic Mapping: A Pilot Study for Porta Hepatis Lymph Node Identification (2001) (8)
Localization of endogenous beta-galactoside-binding lectin in human cells and tissues. (1991) (8)
Intraoperative photodynamic therapy as an adjunct to surgery for recurrent rectal cancer (1995) (8)
High prevalence of Inoue-Melnick virus antibodies in patients with colorectal carcinoma. (1992) (8)
Hemostasis in experimental pulmonary injury (1982) (8)
Analysis of inter-(simple sequence repeat) PCR products from human colorectal cancers. (2005) (8)
Phase I and pharmacokinetic evaluation of floxuridine/leucovorin given on the Roswell Park weekly regimen (2004) (8)
Ileal conduits for recurrent unresectable colorectal adenocarcinoma. (1985) (7)
Human villous adenomas engrafted into scid mice survive for prolonged period without malignant transformation. (1994) (7)
Controversies in the surgical management of rectal cancer. (2003) (7)
Report on demographics of gall bladder cancer in Delaware and retrospective review of treatment strategies for gallbladder cancer in a large community cancer center. (2016) (7)
Utility of an oral examination in a surgical clerkship. (1992) (7)
SEER Data: It Can Be Thought Provoking, But Where Do We Go From Here? (2007) (7)
Establishing the multidisciplinary care of patients with cancer in the state of Delaware (2004) (7)
Allelic losses at genomic instability-associated loci in villous adenomas and adjacent colorectal cancers. (2007) (7)
Durable improvement in disease-free survival (DFS) and overall survival (OS) for stage II or III colon cancer treated with leucovorin-modulated fluorouracil (FL): 10-year follow-up of National Surgical Adjuvant Breast and Bowel Project (NSABP) protocol C-03 (2005) (7)
Intergroup randomized phase III study of postoperative oxaliplatin, 5-fluorouracil and leucovorin (mFOLFOX6) vs mFOLFOX6 and bevacizumab (Bev) for patients (pts) with stage II/ III rectal cancer receiving pre-operative chemoradiation. (2016) (7)
Microbiome and colorectal cancer: A review of the past, present, and future. (2021) (7)
Sphincter Preservation for Distal Rectal Cancer: Paradise Lost? (1999) (6)
Follow-up colonoscopy in patients with colorectal adenomatous polyps. (1988) (6)
Oral contraceptives, reproductive factors and p53 gene expression in colorectal cancer. (1997) (6)
Expression of an unusual isozyme of lactate dehydrogenase in the serum of cancer patients and comparison with carcinoembryonic antigen. (1987) (6)
Granulocyte-macrophage colony-stimulating factor as infection prophylaxis in high-risk oncologic surgery. (1996) (6)
The role of pediatric surgery in the medical school curriculum. (1989) (6)
Clinical trials are mandatory for improving surgical cancer care. (2002) (6)
Getting to Better Cancer Care: Results of a Society of Surgical Oncology Survey (2008) (6)
Developing and operating multidisciplinary disease-specific clinics (2006) (6)
Basic science research in postgraduate surgical training: difficulties encountered by clinical scientists. (2009) (6)
SPECIAL ARTICLE Guidelines 2000 for Colon and Rectal Cancer Surgery (2001) (6)
Phase-I clinical trial of sodium cyanate in patients with advanced colorectal carcinoma. (1985) (6)
Clinical studies of the modulation of Ftorafur. (1993) (6)
The value of routine preoperative urologic evaluation in patients with colorectal carcinoma (1987) (5)
Synchronous and metachronous colon lesions in squamous cell carcinoma of the anal canal (1987) (5)
The use of the major anoxic stress response protein P34, the K isozyme of lactate dehydrogenase, and carcinoembryonic antigen in the follow‐up of patients with colorectal adenocarcinoma (1992) (5)
Management of Hereditary Colon Cancer Syndromes (2002) (5)
Serum levels of cancer-associated antigen CA-549 in patients with advanced breast cancer (1989) (5)
Sputum cytology for the detection of pulmonary metastases from colorectal carcinoma (1987) (5)
Do we really need another article on minimally invasive colorectal cancer surgery? (2014) (5)
Colovaginal anastomosis: a unique complication of end-to-end anastomosis stapler use in low anterior resection. (1998) (5)
Erratum: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: A consensus statement (Annals of Surgical Oncology 14 (128-133)DOI: 10.1245/s10434-006-9185-7) (2011) (5)
Regional chemotherapy is indicated after surgical resection of colorectal metastases to the liver: A debate (2003) (5)
Ornithine decarboxylase activity in hepatic and extrahepatic metastases from colorectal cancer (1988) (5)
Fluorouracil and leucovorin: there is a choice. (1993) (5)
Impact of Multidisciplinary Care on Processes of Cancer Care: A Multi-Institutional Study (2016) (5)
Endoscopic surveillance of patients following a curative resection for colorectal cancer (1988) (5)
Re: Tumor boards and the quality of cancer care. (2013) (5)
Secondary urinoma mimicking recurrent tumor as a cause of bilateral ureteral obstruction (1987) (4)
Phase II trial of continuous-infusion iproplatin (CHIP) and 5-fluorouracil (5-FU) in advanced colorectal carcinoma (2004) (4)
Oncology Nurse Care Coordinators as “Navigators” (2006) (4)
Problems encountered in teaching the use of the 65 cm flexible sigmoidoscope in a surgical oncology training program. (1993) (4)
Expression of a high molecular weight mucin-type glycoprotein in human colon cancer as defined by monoclonal antibody 1D3. (1988) (4)
Preoperative cystoscopic findings in resectable rectal adenocarcinoma. (1987) (4)
Retrospective Reviews Can Be Learning Experiences (1999) (3)
Think Globally, Act Locally (2007) (3)
Pandora's box has been opened. (2000) (3)
Combination chemotherapy of cisplatin and 5-fluorouracil for advanced colorectal adenocarcinoma (2004) (3)
Phase II Study of Cisplatin and 5-Fluorouracil (PF) and Mitomycin C, Vincristine, Cisplatin and 5-Fluorouracil (MVPF) in Patients with Metastatic Large Bowel Cancer: An Eastern Cooperative Oncology Group Study (EST 1285) (2004) (3)
Meta-Analysis on the Effect of Pasireotide for Prevention of Postoperative Pancreatic Fistula (2020) (3)
D-14 Monoclonal antibody to carcinoembryonic antigen: immunohistochemical analysis of formalin-fixed, paraffin-embedded human colorectal carcinoma, tumors of non-colorectal origin and normal tissues (2005) (3)
Pancreatic resections: 30 and 90-day outcomes in octogenarians. (2020) (3)
Surgical Oncology Clinics of North America. Foreword. (2012) (3)
Gastric and Esophageal Cancer 2017. (2017) (3)
A Comparison of Colectomy Outcomes Utilizing Open, Laparoscopic, and Robotic Techniques (2020) (3)
Is laparoscopy still needed for staging resectable pancreatic cancer? (2012) (3)
Consistent hepatic metastasis of human colorectal cancer in severe combined immunodeficient mice. (1996) (3)
Hereditary Nonpolyposis Colorectal Carcinoma (1995) (3)
Systemic hypersensitivity reaction following a barium enema examination. (1988) (3)
A phase I study of cisplatinum plus 5-fluorouracil in modulation with citrovorum factor in metastatic colorectal carcinoma. (1991) (2)
Bevacizumab and postoperative complications after hepatic surgery for colorectal metastases. (2009) (2)
Large bowel adenocarcinoma metastases presenting as appendicitis. (1999) (2)
Clinical outcome and benefit of oxaliplatin in colon cancer according to intrinsic subtypes: Results from NRG Oncology/NSABP C-07. (2016) (2)
Phase I clinical trial of ethyl 6-deoxy-3,5-di-O-methyl 6-(3 methyl-3-nitrosoureido)-alpha-D-glucofuranoside (CGP 6809) (2004) (2)
Statin polyp prevention trial in patients with resected colon cancer: NSABP protocol P-5. (2012) (2)
Isolation of Inoue‐Melnick virus from colorectal carcinoma tissues (1993) (2)
Update on surgical resection of liver metastases from colorectal cancer. (2008) (2)
Treatment of peritoneal surface malignancies. (2012) (2)
Collaboration with the community cancer center: benefit for all. (2012) (2)
Precision Medicine. (2020) (2)
Comparison of unique leucovorin and 5-fluorouracil "escalating" and "maximum" dosage strategies. (1987) (2)
Hepatic Artery Ligation for Liver Cancer (1985) (2)
Precision Medicine in Colorectal Surgery. (2020) (2)
Operative Approach to Rectal Cancer: An Anatomical and Technical Description. (2018) (2)
“I’m in a New York State of Mind” (2008) (2)
A combination of 5-fluorouracil and thymidine in advanced colorectal carcinoma (2004) (2)
A new breast cancer marker (BCM) in monitoring disease status (1989) (2)
Unusual presentation of squamous cell carcinoma of the anal canal. (1990) (2)
Biologic modulation of 5-fluorouracil with high-dose leucovorin and combination chemotherapy of 5-fluorouracil and cisplatin in metastatic colorectal adenocarcinoma. (1987) (2)
The Supportive Care of Oncology Patients (SCOOP) Pathway: A Novel Approach to Improving the Patient Experience in the Curative Treatment of Cancer (2019) (2)
Is mitomycin-c necessary in the chemoradiation regimen for anal canal carcinoma? interim results of a phase III randomized intergroup study (1993) (2)
Expression of p27Kip1 and bcl-2, cigarette smoking, and colorectal cancer risk (2000) (2)
Adenocarcinoma of the appendix. (1988) (2)
A phase II trial of 5-fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6) chemotherapy plus bevacizumab (bev) for patients (pts) with unresectable stage IV colon cancer and a synchronous asymptomatic primary tumor: Updated results of NSABP C-10 with definitive survival analysis. (2013) (2)
Surgical management of liver metastases from colorectal cancer. (2006) (2)
Title Glucocorticoids suppress renal cell carcinoma progression by enhancing Na , K-ATPase beta-1 subunit expression Permalink (2015) (1)
Phase Ml Trial of High-Dose Calcium Leucovorin and 5-Fluorouracil in Advanced Colorectal Cancer1 (2006) (1)
Fellowship training in surgical oncology--an international affair. (2008) (1)
Improvement in multidisciplinary cancer care: The National Cancer Institute Community Cancer Centers Program (NCCCP) Multidisciplinary Lung Cancer Conference and Clinics. (2010) (1)
Phase I trial of a new nitrosourea, CGP 6809, given every 2 weeks (2004) (1)
Primary d e n o v o Adenocarcinoma of the Colon Measuring 8 mm in Diameter with Lymph Node Metastases Report of a Case (2005) (1)
Update from Nicholas Petrelli about Article on Pilot Project to Define Criteria for CCOP Clinical Trials Investigators (7/25/09 issue) (2009) (1)
Pancreatic resections: outcomes in octogenarians (2019) (1)
Data on hepatic metastases (1992) (1)
The disclosure slide—Informative or obligatory, 5 years of SSO Cancer Symposium oral presentations (2021) (1)
The SCOOP Program (2018) (1)
Hepatocellular cancer, cholangiocarcinoma, and metastatic tumors of the liver. (2015) (1)
A cost analysis of sorafenib for desmoid tumors (2022) (1)
Genomic Instability in Sporadic Colorectal Cancer (1998) (1)
A phase II and pharmacokinetic study of 6S-leucovorin plus 5-fluorouracil in patients with colorectal carcinoma (2004) (1)
Type-2 dominant cytokine gene expression following hepatic surgery. (2006) (1)
Meta-analysis on the Effect of Pasireotide for Prevention of Postoperative Pancreatic Fistula (2020) (1)
A Collaborative Effort between the Helen F. Graham Cancer Center at Christiana Care, the University of Delaware, and Nemours Biomedical Research (2011) (1)
Human lung tumor cell secretion of interleukin-2 for protection against tumor engraftment (1994) (1)
Will we ever succeed in resolving the adjuvant treatment dilemma in rectal cancer? (2003) (1)
Altered immunoglobulin A (IgA-1) levels in patients with advanced colorectal adenocarcinoma presenting with normal preoperative levels of carcinoembryonic antigen (CEA). (1993) (1)
Colorectal cancer: Prevention and early detection are the issues, not postoperative surveillance (1995) (1)
Management of peritoneal surface malignancy (2003) (1)
Colorectal cancers in patients with the (9A/6A) polymorphism of TGFBR1 exhibit lesser inter-(simple sequence repeat) PCR genomic instability and present clinically at greater age. (2008) (1)
Introducing enhanced navigation and supportive care into the curative treatment of cancer (SCOOP pathway). (2018) (1)
Aminocaproic acid (AMICAR) in advanced colorectal carcinoma (1986) (1)
Technique for packing the perineal wound after a wide perineal dissection for adenocarcinoma of the rectum. (1992) (1)
Abstract 1182: Patient derived xenograft (PDX) of human melanoma to predict clinical responses (2014) (0)
Health-Care Workers’ Perception of Reimbursement for Complex Surgical Oncology Procedures (2020) (0)
Abstract A201: Mutation profiling and prognostic value of BRAF, HRAS, KRAS, MET, NRAS, PIK3CA, KRASG12V in colon cancer: Results from NSABP C‐07 (2009) (0)
Abstract A01: A comprehensive collection of patient derived xenografts of human melanoma with clinical, genomic, and biological characterization (2016) (0)
Abstract 3931: Sodium-calcium exchanger-1 regulates the epithelial phenotype and is lost in renal cancers (2017) (0)
The Delaware Cancer Consortium (2017) (0)
NSABP Trial R-O4 and ECOG Trial 5204 (2007) (0)
The Evolution of Radical Cancer Surgery (2005) (0)
Progress in surgical oncology: a European perspective. Foreword. (2008) (0)
Safety and Efficacy ofArcitumomab Imaging in Colorectal CancerAfter Repeated Administration (2000) (0)
Surgical Oncology Clinics of North America. The Role of Genetic Testing in Surgical Oncology. Foreword. (2015) (0)
Dr. Constantine Karakousis: The Quintessential Surgical Oncologist (2022) (0)
Serum IgA1 as a tumor associated marker in colorectal cancer patients (1989) (0)
Characteristics of Gastrointestinal Stromal Tumors incidentally discovered during abdominal surgery. (2020) (0)
ssDNA Oligonucleotides Arrest Growth of Esophageal Cancer ells (2007) (0)
Fundoplication wrap disruption: an experimental study in rats. (1998) (0)
Device to aid in exposure for liver resections. (1987) (0)
18. CEA-SCAN™ can be used to predict resectability of recurrent colorectal cancer (1996) (0)
Suppression of endonuclease expression by nonsteroidal antiinflammatory drugs (NSAID's) in sporadic colorectal cancer (1998) (0)
Cancer Care in Delaware: A National Model (2017) (0)
Barrett's esophagus and cancer. Foreword. (2009) (0)
Community-based surveillance in clinical stage I germ cell tumors (2012) (0)
Palliative surgical oncology (2004) (0)
IgA1 with altered carbohydrate structure in follow-up of colorectal cancer patients (1989) (0)
Improved hMLH1 and hMSH2 mutation detection using denaturing high performance liquid chromatography analysis (2001) (0)
Local Surgical Treatment of Hepatic Metastases from Colorectal Carcinoma: Survival Times and Sites of Recurrence (1986) (0)
Neoadjuvant Therapy for Pancreatic Cancer: What Is the Optimal Duration of Treatment? (2021) (0)
Abdominal Intraoperative Ultrasonography, Masatoshi Makuuchi. Igaku-Shoin, Tokyo, Japan (1987), 214 pages. $80.00 (1988) (0)
Surgical Oncology. Editorial. (2013) (0)
Pancreatic Neoplasms. (2016) (0)
Sporadic colorectal carcinoma microdissection: a novel laboratory technique to identify tumor suppressor genes1 (1999) (0)
Preliminary report of γ-enolase levels in patients with bronchogenic carcinoma (1991) (0)
2000 U pdate o f A merican S ociety o f C linical O ncology Colorectal C ancer S urveillance G uidelines (2000) (0)
Sorafenib for Desmoid Tumors. A Cost Analysis: Too Much for Too Little? (2020) (0)
COLLECTIVE REVIEW Anal Canal and Perianal Epidermoid Cancers (2005) (0)
The new Editors of Surgical Oncology. (2014) (0)
Ornithine Decarboxylase (ODC) and S-Adenosylmethionine Decarboxylase (AdoMetDC) as Markers in Human Colonic Neoplasia (1990) (0)
The multidisciplinary management of anal cancer (2004) (0)
CLINICAL UTILITY OF IMAGING WITH 99=TC-LABELED IMMU-4 Fab' FRAGMENT IN PATIENTS(pts) WITH CANCER OF THE COLON OR RECTUM (1994) (0)
Precision Medicine in Surgical Oncology (2020) (0)
Surgical Oncology Clinics of North America. Practical radiation oncology for surgeons. Foreword. (2013) (0)
Abstract PR02: Humanized mouse melanoma model using patient-derived xenografts (2016) (0)
Biliary tract cancers. Foreword. (2009) (0)
Current diagnosis and therapy for head and neck malignancies (2004) (0)
Assessment of numerical chromosome abnormalities in thyroid neoplasia by fluorescence in situ hybridization (1997) (0)
Ablative procedures in surgical oncology. Foreword. (2011) (0)
Emerging perspectives in soft tissue sarcoma (2003) (0)
Early-Stage breast cancer: new developments and controversies. Foreword. (2010) (0)
Treatment of colorectal cancer. Foreword. (2014) (0)
A multidisciplinary team approach to cancer care in a community based teaching hospital (2004) (0)
Hereditary colorectal cancer. Foreword. (2009) (0)
768: IMPROVEMENT IN OPERATIVE TIMES WITH COOPERATIVE PANCREATICODUODENECTOMY AT AN ACADEMIC COMMUNITY CANCER CENTER (2022) (0)
Absence of frequent involvement of modifier of MinAPC in sporadic colorectal cancer (1998) (0)
Foreword. Regional chemotherapy for cancer inclusive of perfusion and infusion techniques. (2008) (0)
Lung Cancer. (2016) (0)
State-wide Retrospective Review of Familial Pancreatic Cancer in Delaware and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds: ACG Lawlor Resident Award: 200 (2013) (0)
Complex distal pancreatectomy performed at a community cancer center (2018) (0)
Outcomes research in surgical oncology. Foreword. (2012) (0)
93rd annual convention podium and poster abstracts (1994) (0)
A Multi-Disciplinary Approach to Cancer Care: The Beginning of a New Era (2003) (0)
Cost Comparison of Laparoscopic and Robotic Colon Resections at a Hybrid Academic/Community Institution (2020) (0)
Adjuvant therapy of pancreatic adenocarcinoma (2004) (0)
Agenesis of the gallbladder. (1987) (0)
Editorial -March issue surgical oncology. (2018) (0)
Surgical oncology clinics of North America. Translational research in surgical oncology. Foreword. (2008) (0)
Primary and metastatic liver cancer (2003) (0)
Surgical Oncology Clinics of North America. Biliary tract and primary liver tumors. Foreword. (2014) (0)
Rectal Cancer Management- no longer a solo sport for surgeons. (2018) (0)
A REFLECTION ON USING FACE-TO-FACE PEER REVIEW AS A METHOD OF PROVIDING FORMATIVE FEEDBACK (2018) (0)
A critical appraisal: providing care for patients with solid tumors metastases--challenges across academic and community practice. (2007) (0)
Hepatic Colorectal Metastasis : Current Status of Surgical Therapy (2017) (0)
Patients with Cancer, Comorbidities, and No Primary Care Provider (2022) (0)
Ann. Surg. Oncol., Vol. 13, No. 2, February 2006, pp. 137–139 (DOI: 10.1245/ASO.2006.05.059) (2006) (0)
A long overdue discussion of head and neck cancer. (2015) (0)
Screening for Cancer: Controversy, Challenges and Opportunity (2005) (0)
High volume pancreaticoduodenectomy performed at a community cancer center (2018) (0)
Abstract 4668: Targeted, massively parallel sequencing identifies novel genetic subsets of cutaneous melanoma (2015) (0)
Randomized clinical trials in surgical oncology. Foreword. (2010) (0)
Delayed cervical esophagogastric anastomosis. (1999) (0)
Treatment outcomes in stage IIIA non-small-cell lung cancer in a community cancer center. (2015) (0)
Consensus statement and clinical pathway for the management of colon cancer with peritoneal metastases in the state of Delaware. (2023) (0)
Biliary tract cancer (2002) (0)
Introduction Cigarette smoking is associated with the development of many cancers . Results from epidemiological studies investigating its role in colorectal cancer have been (2001) (0)
It's going to be in the genes. (2014) (0)
What are the appropriate controls for a colonoscopic screening program? (1993) (0)
Opinion: Lymph Node Dissection for Stage I Melanoma: The unresolved dilemma (1982) (0)
Pancreatic cancer: foreword. (2010) (0)
Advances in management of colorectal cancer. (2022) (0)
Dramatic improvement of the impact factor for surgical oncology. (2016) (0)
Surgical Management of Pelvic Malignancy (2005) (0)
Use of electrospun collagen scaffolds as 3-D cellular models for testing anti-neoplastic agents (2008) (0)
Anal Cancer 2016. (2017) (0)
Laparoscopic approaches in oncology. Foreword. (2013) (0)
Imaging in oncology. (2014) (0)
Surgical Oncology Clinics of North America. Multidisciplinary care of the cancer patient. Foreword. (2013) (0)
Quality of life. (1985) (0)
A multidisciplinary team approach to cancer care in a community based teaching hospital. (2004) (0)
Interet clinique de l'immunoscintigraphie avec le fragment d'anticorps Fab'-Immu-4 marque au 99mTc avant reintervention chirurgicale dans le cancer du colon ou du rectum (1996) (0)
Society of Surgical Oncology Heritage Award: Honoring Glenn D. Steele, Jr, MD, PhD (2008) (0)
A comparison of the Sendai and Fukuoka guidelines for side branch intraductal pancreatic mucinous neoplasms at a single institution (2019) (0)
Erratum: Anal Canal and Perianal Epidermoid Cancers (Journal of American Colleges of Surgeons (November 1997) 185 (494-505)) (1998) (0)
Dissection for melanoma: Author's reply (1983) (0)
Has technology had an impact on survival in patients with recurrent colorectal cancer? (1997) (0)
Effect of pyloric drainage on the healing of esophagogastric anastomoses in rats. (2000) (0)
American Society of Colon and Rectal Surgeons 95th Annual Convention Podium and Poster Abstracts June 9–14, 1996 Seattle, Washington (1996) (0)
American Society of Colon and Rectal Surgeons 95th Annual Convention Podium and Poster Abstracts June 9–14, 1996 Seattle, Washington (1996) (0)
NSABP FC‐6: Surgical conversion rate in colorectal cancer patients with unresectable, KRAS wild‐type liver metastases receiving mFOLFOX7 plus cetuximab (2022) (0)
Translational cancer research for surgeons. Foreword. (2013) (0)
Breast cancer. (2014) (0)
Management of gastric cancer. Foreword. (2012) (0)
Abstract 4247: MicroRNA profile of the human colonic crypt base region is predictive of colon cancer (2010) (0)
To detect Lynch syndrome patients, which colorectal cancers should be tested for microsatellite instability? (2010) (0)
A statewide evaluation of adjuvant chemotherapy for stage III colon cancer. (2011) (0)
Foreword: Novel Insights into the Diagnosis and Treatment of Melanoma (2006) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Nicholas J. Petrelli?

Nicholas J. Petrelli is affiliated with the following schools:

Nicholas J. Petrelli's Academic­Influence.com Rankings

Why Is Nicholas J. Petrelli Influential?

Nicholas J. Petrelli's Published Works

Published Works

What Schools Are Affiliated With Nicholas J. Petrelli?

Nicholas J. Petrelli's AcademicInfluence.com Rankings